A Phase II Trial of 72-Hour Continuous IV Infusion of 9-Aminocamptothecin With G-CSF Support in Patients With Advanced Ovarian Cancer Previously Treated With Paclitaxel and Cisplatin

Completed · Phase 2

Conditions studied: Ovarian Neoplasms

In brief

The objectives of this study are to determine the response rate to 9-AC in patients with advanced ovarian cancer who have recurrent disease after paclitaxel- and cisplatin-based chemotherapy regimens.

Key facts

Study ID

NCT00001427

Run by

National Cancer Institute (NCI)

People needed

40

Starts

1995-01-01

Expected to finish

2000-04-01

Last updated by the study team

2008-03-04

Who can join

Age: any. Sex: female. Healthy volunteers: not accepted.

Where it is running

• National Cancer Institute (NCI) — Bethesda, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.